Fellowship · Houston, TX
Sponsored by Houston Methodist Hospital
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers.
Nature · 2025 · 225 citations · Carlos Ramos, Premal Lulla, Helen Heslop, Malcolm Brenner
Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC).
European urology · 2025 · 123 citations · Eleni Efstathiou
From bench to bedside: the history and progress of CAR T cell therapy.
Frontiers in immunology · 2023 · 365 citations · Siddhartha Ganguly
Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 308 citations · Eleni Efstathiou
Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis.
Journal of hepatology · 2025 · 91 citations · Maen Abdelrahim
Unanswered questions following reports of secondary malignancies after CAR-T cell therapy.
Nature medicine · 2024 · 191 citations · Helen Heslop
Side-effect management of chimeric antigen receptor (CAR) T-cell therapy.
Annals of oncology : official journal of the European Society for Medical Oncology · 2021 · 410 citations · Carlos Ramos
Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion.
Nature reviews. Clinical oncology · 2022 · 279 citations · Carlos Ramos